ANXA1 and malignant colon neoplasm: Taken together, in both colon cancer and RC, high ANXA1 expression is associated with therapy resistance and apoptosis inhibition, while its suppression promotes cell death by reducing the anti-apoptotic markers, i.e., Bcl-2, and by increasing pro-apoptotic proteins, i.e., Bax.